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ABSTRACT
RNA–polypeptide complexes (RNPs), which play
various roles in extant biological systems, have
been suggested to have been important in the
early stages of the molecular evolution of life. At a
certain developmental stage of ancient RNPs, their
RNA and polypeptide components have been pro-
posed to evolve in a reciprocal manner to establish
highly elaborate structures and functions. We have
constructed a simple model system, from which
a cooperative evolution system of RNA and poly-
peptide components could be developed. Based
on the observation that several RNAs modestly
accelerated the chemical ligation of the two basic
peptides. We have designed an RNA molecule
possessing two peptide binding sites that capture
the two peptides. This designed RNA can also
accelerate the peptide ligation. The resulting
ligated peptide, which has two RNA-binding sites,
can in turn function as a trans-acting factor that
enhances the endonuclease activity catalyzed by
the designed RNA.
INTRODUCTION
RNA–polypeptide complexes (also called RNA–protein
or ribonucleoprotein complexes and abbreviated as
RNP) play crucial roles in various aspects of extant cellu-
lar biosystems (1–5). RNP has also been suggested to
have played pivotal roles in the evolution of the modern
DNA–protein world from the hypothetical RNA world
(1,6–8).
In the RNA world hypothesis, the RNP world was pro-
posed to exist as an intermediate stage between the RNA
world and the modern DNA–protein world (1,6–8).
Several RNPs, which still play crucial roles in extant
cellular systems, have been suggested to have evolved
from RNA enzymes (ribozymes) by gradual replacement
of their structural RNA modules with trans-acting
polypeptides (9–17). Through gradual replacement of
structural modules, polypeptides could be incorporated
into the RNA-based primitive life system.
After the isofunctional replacement of RNA modules
with polypeptides, the ancient RNPs would have further
evolved to more complex and sophisticated forms through
developing reciprocal and cooperative evolution systems
(18–24). To provide a simple model system for cooperative
evolution between RNAs and polypeptides in the RNP
world, several RNP systems have been designed in which
the processing (ligation or cleavage) of RNA component is
facilitated through binding with polypeptide components
(25–30). On the other hand, the complementary system, in
which processing of the polypeptide component was facili-
tated by RNA components, has not been reported.
MATERIALS AND METHODS
General
DNase I was purchased from Promega Japan (Tokyo,
Japan). Sephadex G-50 spin column was purchased from
GE Healthcare Japan (Tokyo, Japan). FAM-labeled sub-
strate RNA and Human let-7a RNA were purchased from
JBIOS (Tsukuba, Japan). Preparation of peptides is
described in the supporting information.
Preparation of RNAs
Plasmids encoding the Tetrahymena ribozyme, the Tet-
boxB/RRE RNA and its mutants were described pre-
viously (27,28). These plasmids were used for template
for PCR reactions with a set of primers that are Sense-
L21 (50-CTAATACGACTCACTATAGGAGGGAAAA
GTTATCAGGCA-30) and Antisense-L21 (50-ACTCCA
AAACTAATCAATAT-30). The resulting PCR products
were used as templates for in vitro transcription. A tem-
plate DNA for the Homo sapiens tyrosine-tRNA was PCR
ampliﬁed using plasmid pHSTY (31) as a template and a
set of primers that are T7pro (50-CTAATACGACTCACT
ATAGG-30) and kyi-55 (50-TGGTCCTTCGAGCCGGA
ATCGAAC-30). A template DNA for Escherichia coli
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E. coli JM109 as a template and a set of primers kyi-53
(50-CTAATACGACTCACTATAGGGAGCTGACCAG
ACAGTCGCCGCTTCGTC-30) and kyi-54 (50-GGGAA
CTGACCGATAAGCCGGGTTCTGTCGT-30). In vitro
transcription reactions with T7 RNA polymerase were
performed as described (27,28). The transcription pro-
ducts were puriﬁed on 5% denaturing polyacrylamide
gels. RNAs isolated from the gels were passed through
Sephadex G-50 spin columns. The concentrations of
RNAs were determined from intensities of UV absorption
at 260nm.
Peptide ligation experiments
The chemical ligations of peptides were performed as
follows. After denaturation of RNA (7.5mM) in water
for 5min at 808C, concentrated reaction buﬀer [ﬁnal com-
positions of the reaction mixture were 40mM HEPES
(pH8.0), 80mM KCl and 2mM MgCl2] was added and
the mixture was heated for 5min at 508C. The solution
was cooled at room temperature. Reaction, which
was started by adding peptide (7.5mM) and 1% (w/v)
2-mercaptoethanesulfonate (MESNA), was performed at
378C. Samples (20ml) were quenched with 2ml of 40%
aqueous TFA and the reaction mixtures were analyzed
by using analytical HPLC with CosmoSil 5C18-AR-a
(4.6x25mm). Gradient conditions for CH3CN in 0.1%
aqueous TFA were as follows: 5–60% in 45min; ﬂow
rate: 1ml/min. The fractions corresponding to major
products were collected and their molecular weights were
analyzed by mass spectrometry. All experiments were
repeated at least twice. Their mean values are shown
in ﬁgures wherein error bars indicate their minimal and
maximal values.
Assay forendonuclease ribozyme activity
L21-WT, L21-boxB/RRE or L21-boxB/RRE mut 11nt
dissolved in H2O was heated to 808C for 5min and then
pre-folded in a solution containing 44mM HEPES
(pH8.0), 88mM KCl, appropriate concentration of
MgCl2 with or without the ligated peptide at 378C for
1min. After 5min at 378C, the reaction was started at
378C by adding the FAM-labeled substrate RNA
(50-FAM-GGCCCUCCAAAAA-30). Final composition
of the reactions mixture was as follows: 40mM HEPES
(pH8.0), 80mM KCl, appropriate concentration of
MgCl2,1 mM L21 form RNA, 1mM the ligated peptide
and 0.5mM FAM-labeled substrate RNA. Aliquots of
10ml were removed from the reaction mixtures at
speciﬁed times and quenched by adding an equal volume
of 90mM EDTA in 82% formamide. Substrates and
products were separated by electrophoresis on 20% poly-
acrylamide gels containing 8M urea. The ratios of
products to substrates were quantitated using a Bio-Rad
PharosFX Molecular Imager. All experiments were
repeated at least twice. Their mean values are shown
in ﬁgures wherein error bars indicate their minimal and
maximal values.
RESULTS
Effects of RNA on chemical ligation of twoarginine-rich
peptides
Some ribozymes and other functional RNAs found in
extant biosystems have been proposed to be molecular
fossils of the hypothetical RNA world (1,32,33).
Therefore, we ﬁrst investigated the eﬀects of RNA mole-
cules on the chemical ligation between two model peptides
(Figure S1). We designed and employed two positively
charged peptides derived from phage  N-protein and
HIV Rev-protein (Figure 1A). The minimal RNA-binding
regions of the two proteins (positions 1–19 of N-protein
and positions 34–50 of Rev-protein) have several arginine
residues and speciﬁcally recognize their target RNA
motifs. The 3D structures of N1–19 and Rev34–50 frag-
ments have been elucidated by nuclear magnetic resonance
(NMR) as complexes with their target RNAs (34,35). To
design a peptide ligation system, we added several amino
acids to the carboxy terminal of N1–19 fragment and the
amino terminal of the Rev34–50 fragment to enhance the
ﬂexibility of the two termini. For the chemical reaction
between the two peptides, we also introduced a reactive
thioester onto the carboxy terminal of the N-peptide
and a thiol moiety to the amino terminal of the Rev-
peptide. The two termini can perform ‘native chemical
ligation’, which produces a native peptide bond
(Figure S1) (36).
Before examining the template eﬀects of RNA mole-
cules, we tested the basal reactivity of the chemical peptide
ligation without RNA (Figure 1B and C). The reaction
was monitored by reverse-phase HPLC and a new chro-
matography peak (peak 3 in Figure 1B) was assigned to
the ligated peptide by Matrix Assisted Laser Desorption/
Ionization-Time of Flight (MALDI-TOF) mass spectro-
metry. However, the product yield of the ligation reaction
was low (5.5%) even after 7h incubation, presumably
because the concentration of each peptide (7.5mM) was
much lower than the typical concentration for ligations
in peptide chemistry (millimolar range) (36).
We then investigated the eﬀects of RNA molecules
using four noncoding RNAs; Human let-7a microRNA
(37), the Human tyrosine-tRNA (31), E. coli RNaseP
RNA (38) and a shortened form of the group I intron
from Tetrahymena thermophila (abbreviated as L21-WT)
(39). When the ligation reactions were carried out in the
presence of the respective RNA at 7.5mM, the amount of
the ligated product was markedly improved (Figure 1B).
Judging from the product yield after 7h reaction
(Figure 1C), L21-WT RNA was most eﬀective, whereas
the eﬀects of miRNA and tRNA were modest. These
results demonstrated primitive ability of self-folding
RNAs to facilitate the chemical ligation of two arginine-
rich peptides. As these four RNAs have no speciﬁc bind-
ing sites for the N- and Rev-peptides, the ligation should
be enhanced through nonspeciﬁc association between argi-
nine-rich peptides and RNAs, which would be supported
by electrostatic interaction between positively charged
arginine side chains in peptides and negatively charged
phosphates in the RNA backbone (40,41).
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self-folding RNA
Based on the observation that L21-WT RNA can be used
for primitive templated catalysis of the ligation of argi-
nine-rich peptides, we then attempted to improve the
ability of self-folding RNA. To engineer a variant of
L21-WT RNA capable of capturing the substrate peptides
speciﬁcally, we rationally introduced two peptide binding
sites to L21-WT RNA (Figure 2A). Previously, the
Tetrahymena group I intron ribozyme (which is the paren-
tal form of L21-WT) was rationally converted to a pep-
tide-dependent allosteric ribozyme by inclusion of two
peptide binding sites in two particular regions in the
RNA (P5b and P6b, see Figure 2A) (28). On a model
3D structure of the resulting derivative (abbreviated as
Tet-boxB/RRE), N- and Rev-peptides can bind Tet-
boxB/RRE simultaneously to form a ternary RNA–pep-
tide complex, in which the two reactive peptide termini
could be placed in close proximity (Figure 2B). Based on
this molecular modeling, we decided to use the L21 form
of Tet-boxB/RRE ribozyme (designated L21-boxB/RRE)
as an RNA component for RNA-dependent peptide
ligation.
Before the peptide ligation experiment, we investigated
the structural stability of L21-boxB/RRE in the buﬀer
employed in the peptide ligation assay. We analyzed the
stability of L21-boxB/RRE and L21-WT by assaying
their intrinsic ribozyme activities. L21-WT acts as an
RNA catalyst for site-speciﬁc cleavage of a short RNA
oligomer and this activity sensitively reﬂects the stability
of the correctly folded L21-WT RNA (39). As L21-WT
has been shown to fold into a catalytically proﬁcient struc-
ture in the presence of 2mM Mg
2+ (42,43), it can be used
as a positive control to evaluate the stability of the
L21-boxB/RRE. In the presence of 2mM Mg
2+, endonu-
clease activities of the two RNAs were virtually identical
(Figure 2C). On the other hand, L21-UUCG, a variant
known to require a higher concentration of Mg
2+ ions
for folding, was markedly less active (Figure 2C) (44).
These results indicated that in the presence of 2mM
Mg
2+, the L21-boxB/RRE can fold into the correct 3D
structure and its stability was comparable to that of
L21-WT.
Ligation reactions between N- and Rev- peptides
(7.5mM each) without RNA, with 7.5mM L21-WT and
7.5mM L21-boxB/RRE were examined (Figure 3).
Ligation proceeded better in the presence of L21-boxB/
RRE than the reactions without RNA and with
L21-WT. For 7h reaction, the yield of ligated peptide
with L21-boxB/RRE was 64%, which was 12-fold or
1.4-fold higher than the yields without RNA (5.5%) or
with L21-WT (47%), respectively (Figure 3C). More
importantly, the template eﬀect of L21-boxB/RRE was
more remarkable in 1h reaction, in which the product
yield (35%) was 70- or 6.6-fold higher than those without
RNA (0.5%) or with L21-WT (5.3%), respectively
(Figure 3C).
The peptide ligation proceeded more eﬃciently in the
presence of L21-boxB/RRE than in the presence of other
RNAs although the eﬀects of installation of the two pep-
tide binding sites were modest.
Peptide ligation withmutant L21-boxB/RRE
To examine the importance of the ternary complex com-
posed of L21-boxB/RRE RNA and the two substrate
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Figure 1. Eﬀects of self-folding RNAs on chemical peptide ligation. (A)
Amino-acid sequences of N-peptide, and Rev-peptide employed in this
study. The sequences of N1–19 and Rev34–50 are underlined in the N-
peptide and Rev-peptide, respectively. Chemical ligation was designed
to proceed between Gly26 of the N-peptide and Cys1 of Rev-peptide.
(B) Eﬀects of RNAs on chemical ligation between the N- and Rev-
peptides. Reactions were carried out for 7h and the products were
analyzed by reverse-phase HPLC. Peaks 1, 2 and 3 correspond to the
Rev-peptide, N-peptide and ligated peptide, respectively. The asterisk
indicates N-peptide possessing C-terminal carboxylic acid produced by
thioester hydrolysis. (C) Product yields of the ligated peptide in the
absence or presence of RNAs. Reactions were carried out for 7h.
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of L21-boxB/RRE by disrupting one of the two peptide
binding motifs (Figure 4A). L21-UUCG/RRE and
L21-boxB/mutRRE were incapable of recognizing the
N- and Rev-peptide, respectively, because of mutations
in the corresponding peptide binding motifs (28). The
product yields after 1h reaction showed that the ligation
reactions with L21-UUCG/RRE (6.0%) and L21-boxB/
mutRRE (5.6%) were less eﬃcient than that with the
L21-boxB/RRE (35%) but comparable to that with
L21-WT (5.3%) (Figure 4B).
Effects ofRNAs on ligation of peptides missing arginine
To determine the importance of the RNA-binding abilities
of the peptide component, substitutions were introduced
into the peptide side chains to eliminate their RNA-bind-
ing abilities. In the mutant N-peptide and Rev-
peptide, several important arginine residues were replaced
with alanines (Figure 5A) (27).
In the presence of L21-boxB/RRE, ligation between
mutant N-peptide and Rev-peptide (4.6%) or between
N-peptide and mutant Rev-peptide (15%, Figure 5B) was
much less eﬃcient than the parental combination (N- and
Rev-peptides: 64%) (Figure 5C). Consistent with these
results, reaction between the mutant N- and Rev-peptides
was also ineﬃcient (7.4%) even in the presence of
L21-boxB/RRE. The product yields of these reactions
(4.6–15%) were similar to the ligation reaction without
RNA component (5.5%), and lower than that in the pres-
ence of L21-WT (47%) (Figure 5C). This observation indi-
cated that substitution of positively charged arginines with
uncharged alanines in one peptide canceled the template
eﬀects of RNA, presumably because the mutant peptides
abolished electrostatic aﬃnity to RNA components.
L21-boxB/RRE suppressed ligation ofpeptides bearing
reactive groups in oppositetermini
In the ternary complex between L21-boxB/RRE and two
peptides, relative orientation and distance of the reactive
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Nucleic Acids Research,2009, Vol.37, No. 8 2577groups in two peptides must be a factor contributing for
modest acceleration of the reaction. To see contribution of
this factor, we designed variant N- and Rev-peptides that
can be speciﬁcally recognized by the L21-boxB/RRE
RNA (Figure 6A). However, the two reactive groups
were attached at the opposite termini of the original pep-
tides (Figure 6B). The variant N- and Rev-peptides
(termed cysN- and thioRev-peptides, respectively) have
cysteine and thioester at their amino- and carboxy-
termini, respectively (Figure 6C). Therefore, cysN- and
thioRev-peptides should interact with RNAs as strongly
as the original N- and Rev- peptides because the amino-
acid sequences contributing directly to RNA recognition
were completely preserved.
We ﬁrst evaluated the nonspeciﬁc association between
the variant peptides and the self-folding RNA using
L21-WT. In the presence of 7.5mM L21-WT, ligation
reaction between cysN- and thioRev-peptides proceeded
as eﬃciently as that between the original N- and Rev-
peptides (Figure 6D).
We then examined the eﬀects of L21-boxB/RRE, which
was expected to modestly impair the ligation because
the variant peptides would be ﬁxed in unfavorable
orientations. After 1h ligation reaction in the presence of
L21-boxB/RRE, the yield of ligation between cysN- and
thioRev-peptides (3.2%)was11-foldlessthanthatbetween
N- and Rev-peptides (35%) (Figure 6E). After 17h ligation
reaction, the yield of ligated product in the reaction in the
presence of 7.5mM L21-boxB/RRE (24%) was 3.3-fold less
than the yield of the reaction of the original N- and Rev-
peptides with L21-boxB/RRE (79%) (Figure 6E).
The ligated peptidecan enhance ribozyme activity of
L21-boxB/RRE
Tet-boxB/RRE RNA derived from the full-length
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2578 Nucleic Acids Research, 2009, Vol. 37,No. 8exons performs in vitro splicing reaction triggered by gua-
nosine cofactor (28). Under conditions where the structure
of the Tet-boxB/RRE was marginally stable, the popula-
tion of RNA molecules folded into a splicing-proﬁcient
structure was increased by addition of artiﬁcial peptide
activators (28). The peptide activators have two RNA-
binding motifs connected by linker sequences. The two
RNA-binding motifs simultaneously bind to the target
sites in P5b and P6 regions in Tet-boxB/RRE RNA,
enabling the peptide activator to clamp P5b and P6
regions and stabilize the hairpin structure of P4-P6
domain (28). The amino-acid sequence of one peptide
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Nucleic Acids Research,2009, Vol.37, No. 8 2579activator (pep-G) was almost identical to the peptide
product of the ligation reaction in this study
(Figure 7A). This prompted us to examine whether the
ligated peptide can increase the population of correctly
folded L21-boxB/RRE although the folding process and
structural stability may be diﬀerent between the self-spli-
cing form RNA and L21 form RNA (45,46).
In the presence of 2mM Mg
2+, L21-boxB/RRE was
as active as L21-WT in the endonuclease activity assay,
indicating that the correct structure of L21-boxB/RRE
was stably established. Therefore, we reduced Mg
2+ ion
concentration. At Mg
2+ concentrations of 1mM or more,
the endonuclease activity of L21-boxB/RRE was indistin-
guishable from that of L21-WT (Figure 7C). At 0.7mM
Mg
2+, however, L-21-boxB/RRE was less active than
L21-WT, presumably because the GAAAA pentaloop in
the P5b region of L-21-boxB/RRE interacts with 11ntR
in the P6 region less strongly than the GAAA tetraloop in
L21-WT (34,47). Consistent with this observation,
two other variants in which P5b-P6 interaction is weaker
(L21-boxB/mut11nt/RRE) or disrupted (L21-UUCG)
showed no detectable activity in the presence of
0.7mM Mg
2+.
To determine whether the ligated peptide improved the
endonuclease activity of L21-boxB/RRE, we examined the
eﬀects of the ligated peptide on the reaction at 0.7mM
Mg
2+ (Figure 7B). In the presence of the ligated peptide,
the product yields with 10 and 20min reaction were
1.6- and 1.8-fold better than those without peptide, respec-
tively. Enhancement by the ligated peptide was similar to
that observed in the self-splicing reaction of the Tet-boxB/
RRE RNA with pep-G peptide (from 1.4- to 1.7-fold).
L21-boxB/mut11nt/RRE, which was less active than
L21-boxB/RRE due to weaker P5b–P6 interaction,
was more clearly activated by the ligated peptide in the
presence of 1mM Mg
2+. These results indicated that the
ligated peptide is capable of assisting correct folding of
L21-boxB/RRE or its less stable variant under conditions
where their structures are marginally stable.
DISCUSSION
In the present study, we investigated the abilities of RNAs
as a component for templated catalysis of chemical pep-
tide ligation. We have also developed a designed RNA on
which two RNA-binding peptides can be captured and
ligated (Figure 2). The resulting ligated peptide can in
turn function as a peptide activator to enhance the endo-
nuclease activity of the designed RNA (Figure 7).
Peptide thioester and early evolution of life
In native chemical ligation, the carboxy terminus of one
peptide needs to be activated as a thioester. Native chem-
ical ligation was originally developed as a method of pep-
tide chemistry (40). However, similar chemistry is utilized
in biological reactions. Peptide carboxy terminal thioesters
are used as the activated intermediate in nonribosomal
peptide synthesis and peptide ligation step in protein
splicing (48,49).
In addition to modern biological reactions, peptide and
amino-acid thioesters have been proposed to participate
in the prebiotic world because they can be utilized for
nonenzymatic synthesis of primitive polypeptides. To
investigate the possibility that the thioesters were synthe-
sized under prebiotic conditions, attempts to generate
amino-acid thioester and peptide thioester under prebiotic
conditions have been reported (50–54). Moreover, the pos-
sible roles of thioesters in the hypothetical RNA world
were also examined by generating RNA enzymes for
CoA-thioester synthesis and aminoacylation with CoA-
thioesters through in vitro evolution (55,56). Therefore,
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Figure 7. Eﬀects of the ligated peptide on the endonuclease reaction by
L21-boxB/RRE RNA. (A) Amino-acid sequences of the pepG peptide
and ligated peptide. (B) The endonuclease reactions of L21-WT and its
derivatives in the presence of 0.7mM MgCl2.( C) Endonuclease reac-
tions of L21-WT and its derivatives in the presence of 1mM MgCl2.
2580 Nucleic Acids Research, 2009, Vol. 37,No. 8the RNA-templated peptide ligation system developed in
this study may be useful as a new model system to exploit
the possible link between the RNA world and thioester-
based prebiotic peptide synthesis.
Nonspecific effects ofRNA on peptide ligation
In the present study, self-folding RNAs were shown to
modestly but distinctly accelerate chemical ligation
between the arginine-rich peptides (Figure 1). This result
indicated that RNA molecules are able to serve as primi-
tive templates for RNA ligation through nonspeciﬁc asso-
ciation mediated by electrostatic interaction between
positively charged guanidyl groups and the negatively
charged phosphate moiety. Binding speciﬁcities between
RNA and polypeptide in RNP complexes are often
determined by a limited number of interactions between
particular arginines and base-moieties of nucleotides
(34,35,57). In such cases, other arginines form electrostatic
interactions with phosphate backbone of RNA to improve
the stability of RNP complexes (40). In several cases, how-
ever, nonspeciﬁc interactions are strong enough to exhibit
biologically relevant eﬀects in vitro and in vivo (58,59).
Considering the properties of the arginine-phosphate
interaction, it is conceivable that self-folding RNAs pos-
sess primitive ability to accelerate the chemical ligation of
arginine-rich peptides, in which RNAs would act as tem-
plates that increase the concentrations of arginine-rich
peptides through nonspeciﬁc association.
Templated catalysis of peptideligation by adesigned RNA
Speciﬁc RNA–protein interactions play a variety of bio-
logical roles in living cells (1). In some RNPs, many
proteins bind to one (or a few) RNA molecule(s) to
form multimolecular complexes, where RNA component
can be regarded as a scaﬀold that speciﬁcally arranges
protein components in deﬁned distances and orientations
(1,4,5). The designed RNA (L21-boxB/RRE) employed in
this study can speciﬁcally capture the two arginine-rich
peptides to form a deﬁned ternary complex (Figure 2).
Through comparison of this speciﬁc RNP with those of
nonspeciﬁc RNA–peptide association, the speciﬁc com-
plex was shown to promote the peptide ligation more eﬃ-
ciently than the nonspeciﬁc association although eﬀects of
the peptide binding sites were relatively modest. While the
designed RNA seems to aﬀord entropic advantage mod-
estly to the substrate peptides, the RNA had no catalytic
machinery capable of accelerating the chemical step
(thioester exchange or acyl transfer) in the ligation.
Recent analyses of ribosomal protein synthesis and non-
ribosomal peptide synthesis revealed that their catalytic
sites play crucial roles in proper alignment of substrates
(60,61). On the other hand, there is still debate regarding
whether their catalytic sites directly accelerate the chemi-
cal step by providing general acid/base moieties or coor-
dinating catalytic metal ions (60–62). Therefore, improved
RNA molecules for templated catalysis of peptide ligation
may be developed based on our simple RNP if the
3D structures of RNA components can be elaborated
to enable two reactive termini of peptides to be ﬁxed
highly precisely.
Towardinterdependent system of RNA and polypeptide
In addition to peptide ligation in the presence of the
designed RNA, this study also demonstrated that the
ligated peptide has the ability to enhance the ribozyme
activity of the designed RNA (Figure 7). In this RNP
model system, RNA and peptide components play dual
(active and passive) roles in regulating or transforming
each other’s functions or structures. The RNA component
actively facilitates the ligation of two peptides, whereas
its endonuclease activity was passively regulated by the
ligated peptide. The peptide component serves passively
as a substrate captured by the RNA, whereas the ligated
peptide functions actively as a positive regulator of the
endonuclease activity by the RNA component.
In the RNP system of this study, the RNA component
(L21-boxB/RRE) may not necessarily be suitable for an
integrated RNP system because of its nuclease activity.
It can be readily imagined that RNA ligation reactions
would be more important in the RNA and RNP world
(25,63). However, L21-boxB/RRE would have the poten-
tial to evolve to a ligase ribozyme because its parental
Tetrahymena group I ribozyme has been converted to a
ligase ribozyme and also used as a parental ribozyme in
attempts to create polymerase and replicase ribozymes
(64–66).
This study provided a primitive but potentially
important RNP complex, from which more complex
RNP systems may be developed, that may mimic the
ancient system that emerged during the molecular evolu-
tion of life.
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